Cats may not look like they’re sniffing out mysteries, but their noses are constantly at work—mapping the world, reading signals, and even picking up on your emotions. With up to 200 million ...

GoodRx has announced a collaboration with Sanofi to offer the drugmaker’s Lantus brand of insulin for $35 a month at tens of thousands of U.S. pharmacies, regardless of consumers’ insurance ...

Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...

Currently, an estimated 37.3 million Americans (approximately 11.3% of the U.S. population) have diabetes, and roughly 8.4 million of them use insulin, according to the American Diabetes Association.

Lantus (insulin glargine) is a prescription drug that’s used to help manage blood sugar levels in people with diabetes. This drug can interact with alcohol, other medications, and some supplements.

Sanofi SNY announced up to a 78% cut in the list price of its most popular insulin, Lantus, following the likes of rival Novo Nordisk NVO and Eli Lilly LLY. Similar to Lilly, Sanofi also said it ...

Sanofi's Lantus insulin injection will see its price cut by 78%, the company announced Thursday. The out-of-pocket cost for all patients will be $35 for a monthly supply.

Sanofi plans to take a 78% list-price reduction on Lantus, the company’s most widely used insulin in the U.S., and a 70% cut on its Apidra product starting in January 2024, the company said ...

Eli Lilly, the first to announce insulin price cuts this month, will slash the drugmaker's most commonly prescribed insulin Humalog to $66.40 per vial, down from $274.70.

Introduction Lantus (insulin glargine) is a brand-name prescription drug used to treat diabetes. As with other medications, Lantus can interact with alcohol and certain other drugs.